Status:
COMPLETED
The Oral Microbiome and Upper Aerodigestive Squamous Cell Cancer
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Institutes of Health (NIH)
Conditions:
Oral Cancer
Eligibility:
All Genders
40-92 years
Brief Summary
The human oral cavity is a diverse habitat that contains approximately 700 prokaryotic species. The oral microbiome is comprised of 44% named species, 12% isolates representing unnamed species, and 44...
Detailed Description
The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial and The American Cancer Society Cancer Prevention Study II (CPS-II) investigators have identified 140 UADSCC cases that have be...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosis of Upper Aerodigestive Squamous Cell Cancer and registered in:
- The American Cancer Society Cancer Prevention Study II (CPS-II)
- The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.
Exclusion
Key Trial Info
Start Date :
December 1 1992
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 1 2010
Estimated Enrollment :
560 Patients enrolled
Trial Details
Trial ID
NCT03304132
Start Date
December 1 1992
End Date
December 1 2010
Last Update
October 9 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
New York University School of Medicine
New York, New York, United States, 10016